Skip to content
Screener

Whitehawk Therapeutics WHWK Return on invested capital

Return on invested capital at other companies

Eli Lilly logo
Eli LillyLLY
39.7%+10.3pp
Pfizer logo
PfizerPFE
6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
10.3%-1.5pp
Gilead Sciences logo
Gilead SciencesGILD
-6.7%-24.7pp
AbbVie logo
AbbVieABBV
17.1%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-21.2%-6.9pp

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$232.43M+174%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Calculated from Whitehawk Therapeutics’s reported figures.

Based on trailing twelve months.

The source filing: Whitehawk Therapeutics’s 10-K, filed March 12, 2026. Open the filing →

Filed
Mar 12, 2026, 4:12 PM EDT
Fiscal year
FY2025
Accession
0001193125-26-104158

FAQ

What is Whitehawk Therapeutics's return on invested capital?
Whitehawk Therapeutics (WHWK) reported return on invested capital of -197.8% in Q4 2024.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Ask your AI about Whitehawk Therapeutics's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude